3/22
01:46 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
3/22
01:46 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
3/22
01:12 pm
vor
Rating for VOR
Medium
Report
Rating for VOR
3/22
01:12 pm
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
09:37 am
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
09:37 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock, down previously from $17.00.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock, down previously from $17.00.
3/21
09:37 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
3/21
09:37 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
3/21
09:08 am
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
09:08 am
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
08:58 am
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
08:58 am
vor
Rating for VOR
Medium
Report
Rating for VOR
3/21
08:06 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.